Product Description
Clemastine is used to relieve hay fever and allergy symptoms, including sneezing; runny nose; and red, itchy, tearing eyes. Prescription strength clemastine is also used to relieve the itching and swelling of hives. Clemastine helps control symptoms of allergies and colds but does not treat the cause of these symptoms or speed recovery. Clemastine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. (Sourced from: https://medlineplus.gov/druginfo/meds/a682542.html)
Mechanisms of Action: H1 Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral,Intravenous
FDA Designation: None *
Approval Status: Approved
Approved Countries: Brazil | Canada | Chile | Denmark | Ecuador | Egypt | Estonia | Germany | Hong Kong | Iceland | India | Ireland | Italy | Jordan | Korea | Latvia | Lithuania | Netherlands | Pakistan | Peru | Poland | Portugal | Romania | Russia | Slovenia | South Africa | Sweden | Switzerland | Taiwan | Turkey | Ukraine | United Kingdom | United States | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: Azidus Brasil
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count: 1
Highest Development Phases
Phase 2: Depressive Disorder
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| CLIMB | P2 |
Not yet recruiting |
Depressive Disorder |
2025-01-01 |